Princeton-based biotechnology company Advaxis Inc. announced Monday that it has appointed Sara Bonstein to chief financial officer, senior vice president.<br /><br />According to the announcement, she has a decade of financial leadership experience in the life sciences with Eli Lily & Company, ImClone Systems and New Brunswick-based Johnson & Johnson.<br /><br />While at Eli Lily, she led multiple projects relating to clinical research, project management, finance, manufacturing and commercial sales.  <br /><br />At ImClone, which was acquired by Eli Lily in 2008, she led budget and forecast activities for clinical, preclinical, manufacturing research and development, and cancer therapeutics including Erbitux, a cancer treatment with more than $1.5 billion in annual sales.<br /><br />At Johnson & Johnson, she managed gross-to-net analysis and calculation for about $1.1 billion of pharmaceutical product sales, the announcement said.